BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mathioudakis N, Salvatori R. Management options for persistent postoperative acromegaly. Neurosurg Clin N Am 2012;23:621-38. [PMID: 23040748 DOI: 10.1016/j.nec.2012.06.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Ibrahim SRA, Shkarubo AN, Astafieva LI, Chmutin GE, Chmutin EG. Management of patients with persistent and recurrent acromegaly. Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery) 2021. [DOI: 10.33920/med-01-2104-02] [Reference Citation Analysis]
2 Hogan E, Chittiboina P. Surgical management of growth hormone-secreting adenomas. Gigantism and Acromegaly 2021. [DOI: 10.1016/b978-0-12-814537-1.00012-9] [Reference Citation Analysis]
3 Corica G, Ceraudo M, Campana C, Nista F, Cocchiara F, Boschetti M, Zona G, Criminelli D, Ferone D, Gatto F. Octreotide-Resistant Acromegaly: Challenges and Solutions. Ther Clin Risk Manag 2020;16:379-91. [PMID: 32440136 DOI: 10.2147/TCRM.S183360] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
4 Asha MJ, Takami H, Velasquez C, Oswari S, Almeida JP, Zadeh G, Gentili F. Long-term outcomes of transsphenoidal surgery for management of growth hormone-secreting adenomas: single-center results. J Neurosurg 2019;:1-11. [PMID: 31604330 DOI: 10.3171/2019.6.JNS191187] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
5 Almeida JP, Ruiz-Treviño AS, Liang B, Omay SB, Shetty SR, Chen YN, Anand VK, Grover K, Christos P, Schwartz TH. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature. J Neurosurg 2018;129:404-16. [PMID: 28862548 DOI: 10.3171/2017.2.JNS162673] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
6 Mooney MA, Simon ED, Little AS. Advancing Treatment of Pituitary Adenomas through Targeted Molecular Therapies: The Acromegaly and Cushing Disease Paradigms. Front Surg 2016;3:45. [PMID: 27517036 DOI: 10.3389/fsurg.2016.00045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
7 Brzana J, Yedinak CG, Fleseriu M. Acromegaly, Awareness Is Paramount for Early Diagnosis: Highlights of Diagnosis and Treatment Challenges. A Case-Based Guide to Clinical Endocrinology 2015. [DOI: 10.1007/978-1-4939-2059-4_2] [Reference Citation Analysis]
8 Fleseriu M. The role of combination medical therapy in acromegaly: hope for the nonresponsive patient. Current Opinion in Endocrinology, Diabetes & Obesity 2013;20:321-9. [DOI: 10.1097/med.0b013e32836318a1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]